Notice2021-27635

Bulk Manufacturer of Controlled Substances Application: Organix Inc.

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 21, 2021

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Organix Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 86 Issue 242 (Tuesday, December 21, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 242 (Tuesday, December 21, 2021)]
[Notices]
[Pages 72274-72275]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-27635]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-940]


Bulk Manufacturer of Controlled Substances Application: Organix 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Organix Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before February 22, 
2022. Such persons may also file a written request for a hearing on the 
application on or before February 22, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 16, 2021, Organix Inc., 240 Salem Street, 
Woburn, Massachusetts 01801-2029, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..........            2010  I
Lysergic acid diethylamide.........            7315  I
Marihuana..........................            7360  I
Tetrahydrocannabinols..............            7370  I
Mescaline..........................            7381  I
3,4,5- Trimethoxyamphetamine.......            7390  I
4-Bromo-2,5-dimethoxyphenethylamine            7392  I
3,4-Methylenedioxyamphetamine......            7400  I

[[Page 72275]]

 
3,4-Methylenedioxymethamphetamine..            7405  I
5-Methoxy-N-N-dimethyltryptamine...            7431  I
Alpha-Methyltryptamine.............            7432  I
Bufotenine.........................            7433  I
Diethyltryptamine..................            7434  I
Dimethyltryptamine.................            7435  I
Psilocybin.........................            7437  I
Psilocyn...........................            7438  I
2-(2,5-Dimethoxy-4-methylphenyl)               7508  I
 ethanamine (2C-D).
2-(2,5-Dimethoxyphenyl) ethanamine             7517  I
 (2C-H).
2-(4-Iodo-2,5-dimethoxyphenyl)                 7518  I
 ethanamine (2C-I).
Heroin.............................            9200  I
Morphine...........................            9300  II
------------------------------------------------------------------------

    The company plans to synthesize the above listed controlled 
substances for distribution to its customers. In reference to dug codes 
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans 
to bulk manufacture these drugs as synthetic. No other activities for 
these drug codes are authorized for this registration.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-27635 Filed 12-20-21; 8:45 am]
BILLING CODE 4410-09-P


</pre></body>
</html>
Indexed from Federal Register on December 21, 2021.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.